Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insulin resistance is associated with advanced liver fibrosis and high body mass index in HIV/HCV-coinfected patients.

Literature DB >> 19092449

Insulin resistance is associated with advanced liver fibrosis and high body mass index in HIV/HCV-coinfected patients.

Pablo Ryan, Juan Berenguer, Dariela Michelaud, Pilar Miralles, J M Bellón, Emilio Alvarez, Pilar Catalán, Matilde Sánchez-Conde, Salvador Resino.

Abstract

Entities: Disease Gene Species

Mesh：

Year: 2009 PMID： 19092449 DOI： 10.1097/QAI.0b013e318186ede8

Source DB: PubMed Journal: J Acquir Immune Defic Syndr ISSN： 1525-4135 Impact factor: 3.731

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients.

Authors: Marie-Louise C Vachon; Stephanie H Factor; Andrea D Branch; Maria-Isabel Fiel; Maribel Rodriguez-Torres; Norbert Bräu; Richard K Sterling; Jihad Slim; Andrew H Talal; Douglas T Dieterich; Mark S Sulkowski
Journal: J Hepatol Date: 2010-08-21 Impact factor: 25.083

2. Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.

Authors: M Guzmán-Fulgencio; J Berenguer; M García-Álvarez; D Micheloud; J C López; J Cosín; I Fernández de Castro; P Catalán; P Miralles; S Resino
Journal: Eur J Clin Microbiol Infect Dis Date: 2011-03-26 Impact factor: 3.267

3. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.

Authors: Monica A Konerman; Shruti H Mehta; Catherine G Sutcliffe; Trang Vu; Yvonne Higgins; Michael S Torbenson; Richard D Moore; David L Thomas; Mark S Sulkowski
Journal: Hepatology Date: 2014-01-16 Impact factor: 17.425

Insulin resistance is associated with advanced liver fibrosis and high body mass index in HIV/HCV-coinfected patients.

1. Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients.

2. Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.

3. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.

4. Human immunodeficiency virus and liver disease: An update.

Review 5. Molecular mechanisms of liver fibrosis in HIV/HCV coinfection.

6. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.

Review 7. Portal hypertension as immune mediate disease.